Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD4818 in moderate to severe COPD
NCT00629239Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2008
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of azd-4818 in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jan 2008; status: completed.
02
Drugs
azd-4818
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00629239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629239.